Chapter/Section Purchase

1 Study Coverage
1.1 Nucleic Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Nucleic Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Preventive Nucleic Vaccine
1.2.3 Therapeutic Nucleic Vaccine
1.3 Market by Application
1.3.1 Global Nucleic Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Nucleic Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Nucleic Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Nucleic Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Nucleic Vaccine Sales by Region
2.4.1 Global Nucleic Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Nucleic Vaccine by Region (2023-2028)
2.5 Global Nucleic Vaccine Revenue by Region
2.5.1 Global Nucleic Vaccine Revenue by Region (2017-2022)
2.5.2 Global Nucleic Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Nucleic Vaccine Sales by Manufacturers
3.1.1 Global Top Nucleic Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Nucleic Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Nucleic Vaccine in 2021
3.2 Global Nucleic Vaccine Revenue by Manufacturers
3.2.1 Global Nucleic Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Nucleic Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Nucleic Vaccine Revenue in 2021
3.3 Global Nucleic Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Nucleic Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Nucleic Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Nucleic Vaccine Sales by Type
4.1.1 Global Nucleic Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Nucleic Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Nucleic Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Nucleic Vaccine Revenue by Type
4.2.1 Global Nucleic Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Nucleic Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Nucleic Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Nucleic Vaccine Price by Type
4.3.1 Global Nucleic Vaccine Price by Type (2017-2022)
4.3.2 Global Nucleic Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Nucleic Vaccine Sales by Application
5.1.1 Global Nucleic Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Nucleic Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Nucleic Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Nucleic Vaccine Revenue by Application
5.2.1 Global Nucleic Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Nucleic Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Nucleic Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Nucleic Vaccine Price by Application
5.3.1 Global Nucleic Vaccine Price by Application (2017-2022)
5.3.2 Global Nucleic Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Nucleic Vaccine Market Size by Type
6.1.1 North America Nucleic Vaccine Sales by Type (2017-2028)
6.1.2 North America Nucleic Vaccine Revenue by Type (2017-2028)
6.2 North America Nucleic Vaccine Market Size by Application
6.2.1 North America Nucleic Vaccine Sales by Application (2017-2028)
6.2.2 North America Nucleic Vaccine Revenue by Application (2017-2028)
6.3 North America Nucleic Vaccine Market Size by Country
6.3.1 North America Nucleic Vaccine Sales by Country (2017-2028)
6.3.2 North America Nucleic Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Nucleic Vaccine Market Size by Type
7.1.1 Europe Nucleic Vaccine Sales by Type (2017-2028)
7.1.2 Europe Nucleic Vaccine Revenue by Type (2017-2028)
7.2 Europe Nucleic Vaccine Market Size by Application
7.2.1 Europe Nucleic Vaccine Sales by Application (2017-2028)
7.2.2 Europe Nucleic Vaccine Revenue by Application (2017-2028)
7.3 Europe Nucleic Vaccine Market Size by Country
7.3.1 Europe Nucleic Vaccine Sales by Country (2017-2028)
7.3.2 Europe Nucleic Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Nucleic Vaccine Market Size by Type
8.1.1 Asia Pacific Nucleic Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Nucleic Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Nucleic Vaccine Market Size by Application
8.2.1 Asia Pacific Nucleic Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Nucleic Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Nucleic Vaccine Market Size by Region
8.3.1 Asia Pacific Nucleic Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Nucleic Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Nucleic Vaccine Market Size by Type
9.1.1 Latin America Nucleic Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Nucleic Vaccine Revenue by Type (2017-2028)
9.2 Latin America Nucleic Vaccine Market Size by Application
9.2.1 Latin America Nucleic Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Nucleic Vaccine Revenue by Application (2017-2028)
9.3 Latin America Nucleic Vaccine Market Size by Country
9.3.1 Latin America Nucleic Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Nucleic Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Nucleic Vaccine Market Size by Type
10.1.1 Middle East and Africa Nucleic Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Nucleic Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Nucleic Vaccine Market Size by Application
10.2.1 Middle East and Africa Nucleic Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Nucleic Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Nucleic Vaccine Market Size by Country
10.3.1 Middle East and Africa Nucleic Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Nucleic Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Moderna
11.1.1 Moderna Corporation Information
11.1.2 Moderna Overview
11.1.3 Moderna Nucleic Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Moderna Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Moderna Recent Developments
11.2 CureVac
11.2.1 CureVac Corporation Information
11.2.2 CureVac Overview
11.2.3 CureVac Nucleic Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 CureVac Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CureVac Recent Developments
11.3 Inovio
11.3.1 Inovio Corporation Information
11.3.2 Inovio Overview
11.3.3 Inovio Nucleic Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Inovio Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Inovio Recent Developments
11.4 Sanofi
11.4.1 Sanofi Corporation Information
11.4.2 Sanofi Overview
11.4.3 Sanofi Nucleic Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sanofi Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sanofi Recent Developments
11.5 GSK
11.5.1 GSK Corporation Information
11.5.2 GSK Overview
11.5.3 GSK Nucleic Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 GSK Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GSK Recent Developments
11.6 CNBG
11.6.1 CNBG Corporation Information
11.6.2 CNBG Overview
11.6.3 CNBG Nucleic Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 CNBG Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 CNBG Recent Developments
11.7 Hualan Bio
11.7.1 Hualan Bio Corporation Information
11.7.2 Hualan Bio Overview
11.7.3 Hualan Bio Nucleic Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Hualan Bio Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hualan Bio Recent Developments
11.8 Zhifei Shengwu
11.8.1 Zhifei Shengwu Corporation Information
11.8.2 Zhifei Shengwu Overview
11.8.3 Zhifei Shengwu Nucleic Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Zhifei Shengwu Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Zhifei Shengwu Recent Developments
11.9 Liaoning Chengda
11.9.1 Liaoning Chengda Corporation Information
11.9.2 Liaoning Chengda Overview
11.9.3 Liaoning Chengda Nucleic Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Liaoning Chengda Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Liaoning Chengda Recent Developments
11.10 BioKangtai
11.10.1 BioKangtai Corporation Information
11.10.2 BioKangtai Overview
11.10.3 BioKangtai Nucleic Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 BioKangtai Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 BioKangtai Recent Developments
11.11 CanSinoBIO
11.11.1 CanSinoBIO Corporation Information
11.11.2 CanSinoBIO Overview
11.11.3 CanSinoBIO Nucleic Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 CanSinoBIO Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 CanSinoBIO Recent Developments
11.12 Walvax Biotechnology
11.12.1 Walvax Biotechnology Corporation Information
11.12.2 Walvax Biotechnology Overview
11.12.3 Walvax Biotechnology Nucleic Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Walvax Biotechnology Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Walvax Biotechnology Recent Developments
11.13 Fosun Pharma
11.13.1 Fosun Pharma Corporation Information
11.13.2 Fosun Pharma Overview
11.13.3 Fosun Pharma Nucleic Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Fosun Pharma Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Fosun Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Nucleic Vaccine Industry Chain Analysis
12.2 Nucleic Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Nucleic Vaccine Production Mode & Process
12.4 Nucleic Vaccine Sales and Marketing
12.4.1 Nucleic Vaccine Sales Channels
12.4.2 Nucleic Vaccine Distributors
12.5 Nucleic Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Nucleic Vaccine Industry Trends
13.2 Nucleic Vaccine Market Drivers
13.3 Nucleic Vaccine Market Challenges
13.4 Nucleic Vaccine Market Restraints
14 Key Findings in The Global Nucleic Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer